UPM shares gain after halting Rotterdam bio-refinery project

UPM-Kymmene (UPM) shares rose after the company announced it would discontinue its planned biofuels refinery project in Rotterdam following technical, commercial, and strategic evaluations. Stifel analysts view the cancellation as a positive, citing underperformance of UPM's biofuels operations and improved medium-term cash flow visibility, signaling a focus on profitable growth. UPM will explore lower-capex alternatives, including debottlenecking its Lappeenranta facility and pursuing sustainable aviation fuel qualification for crude tall oil (CTO)-derived fuels.

Analysis

UPM-Kymmene Corp. (HE:UPM) shares experienced an uplift following the company's announcement to cease all engineering and site-related activities for its planned biofuels refinery in Rotterdam, a decision reached after comprehensive technical, commercial, and strategic evaluations. This move is perceived positively by analysts, such as Stifel, who noted that UPM's existing biofuels operations in Lappeenranta, Finland, have underperformed expectations. The cancellation of the Rotterdam project is expected to enhance UPM's medium-term cash flow visibility and signals a strategic pivot towards prioritizing profitable growth over expansion for its own sake. UPM intends to pursue growth in the biofuels sector through lower capital expenditure alternatives, including evaluating the debottlenecking potential of its Lappeenranta facility to meet market demand for crude tall oil (CTO)-based biofuels. Furthermore, the company will continue efforts to qualify CTO-derived fuels as sustainable aviation fuel (SAF) and develop proprietary technologies to diversify its feedstock base. Stifel analysts concur that these alternative strategies, such as Lappeenranta debottlenecking and SAF qualification, present growth avenues with diminished capital risk.

Key Decisions for Investors

• Investors should consider the positive implications of UPM's improved capital discipline and enhanced medium-term cash flow visibility resulting from the cancellation of the high-capex Rotterdam biofuels project.
• Monitor UPM's execution on its revised biofuels strategy, particularly progress in debottlenecking the Lappeenranta facility and achieving SAF qualification for its CTO-derived fuels, as these are now key to lower-risk growth.
• Evaluate how UPM's strategic shift towards profitable growth and potentially higher returns on invested capital aligns with individual portfolio objectives, given the reduced emphasis on large-scale expansion.